RGD-containing peptide GCRGYGRGDSPG reduces enhancement of osteoblast differentiation by poly(L-lysine)-graft-poly(ethylene glycol)-coated titanium surfaces

Journal of Biomedical Materials Research - Part A

Volumn 68, Issue 3, 2004, Pages 458-472

  Tosatti, S ^a   Schwartz, Z ^b,c,d   Campbell, C ^c   Cochran, D L ^c   VandeVondele, S ^a   Hubbell, J A ^a   Denzer, A ^e   Simpson, J ^e   Wieland, M ^e   Lohmann, C H ^f   Textor, M ^a   Boyan, B D ^b,d  

^a ETH ZURICH   (Switzerland)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e Institut Straumann   (Switzerland)

^f UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Differentiation; GCRGYGRGDSPG; Osteoblast; PEG; Poly(ethylene glycol); Poly(L lysine) g poly(ethylene glycol); Proliferation; RGD peptide

Indexed keywords

ABSORPTION; CELLS; GRAFT COPOLYMERS; POLYETHYLENE GLYCOLS; PROTEINS; SURFACE ROUGHNESS; SURFACE TOPOGRAPHY; TISSUE CULTURE; TITANIUM;

CELL ATTACHMENT PROTEINS;

BIOMATERIALS;

ALKALINE PHOSPHATASE; ARGINYLGLYCYLASPARTIC ACID; GLASS; GLYCYLCYSTEINYLARGINYLGLYCYLTYROSYLGLYCYLARGINYLGLYCYLASPARTYLSERYLPROLYLGL YCINE; MACROGOL; OSTEOCALCIN; PEPTIDE; PLASTIC; POLYLYSINE; TITANIUM; UNCLASSIFIED DRUG;

ARTICLE; BONE DEVELOPMENT; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; DOSE RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MATERIAL COATING; OSTEOBLAST;

EID: 10744220422     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.20082     Document Type: Article

References (81)

1. Buser D. Titanium for dental applications (II). In: Brunette DM, Tengvall P, Textor M, Thomsen P, editors. Titanium in medicine. Berlin: Springer-Verlag; 2001. p 875-888.
2. Lincks J, Boyan BD, Blanchard CR, Lohmann Ch, Liu Y, Cochran DL, Dean DD, Schwartz Z. Response of MG63 osteoblast-like cells to titanium and titanium alloy is dependent on surface roughness and composition. Biomaterials 1998;19:2219-2232.
3. Sinha RK, Morris F, Shah SA, Tuan RS. Surface composition of orthopaedic implant metals regulates cell attachment, spreading, and cytoskeletal organization of primary human osteoblasts in vitro. Clin Orthop Rel Res 1994;305:258-272.
4. Puleo DA, Bizios R. Formation of focal contacts by osteoblasts cultured on orthopedic biomaterials. J Biomed Mater Res 1992;26:291-301.
5. Windeler AS, Bonewald LF, Khare AG, Boyan BD, Mundy GR. The influence of sputtered bone substitutes on cell growth and phenotypic expression. In: Davies JE, editor. The bone-biomaterial interface. Toronto: Toronto Press; 1991. p 205-13.
6. Hayman EG, Pierschbacher MD, Ohgren Y, Ruoslahti E. Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc Natl Acad Sci USA 1983;80:4003-4007.
7. Pierschbacher MD, Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984;309:30-33.
8. Massia SP, Hubbell JA. Covalent surface immobilization of Arg-Gly-Asp- and Tyr-Ile-Gly-Ser-Arg-containing peptides to obtain well-defined cell-adhesive substrates. Anal Biochem 1990;187:292-301.
9. Massia SP, Hubbell JA. Human endothelial cell interactions with surface-coupled adhesion peptides on a nonadhesive glass substrate and two polymeric biomaterials. J Biomed Mater Res 1991;25:223-242.
10. Dee KC, Andersen TT, Bizios R. Design and function of novel osteoblast-adhesive peptides for chemical modification of biomaterials. J Biomed Mater Res 1998;40:371-377.
11. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science 1987;238:491-497.
12. Hubbell JA. Biomaterials in tissue engineering. Biotechnology 2003;13:565-576.
13. Healy KE. Molecular engineering of materials for bioreactivity. Curr Opin Solid State Mater Sci 1999;4:381-387.
14. Sinha RK, Tuan RS. Regulation of human osteoblast integrin expression by orthopaedic implant materials. Bone 1996;18:451-457.
15. Pearson BS, Klebe RJ, Boyan BD, Moskowicz D. Comments on the clinical application of fibronectin in dentistry. J Dent Res 1988;67:515-517.
16. Eble JA, Kuhn K. Integrin-ligand interaction. New York: Springer; 1997.
17. Harmenberg J, Hoglund M, Hellstrom-Lindberg E. G- and GM-CSF in oncology and oncological haematology. Eur J Haematol 1994;55(suppl):1-28.
18. Albelda SM, Buck CA. Integrins and other cell adhesion molecules. FASEB J 1990;4:2868-2880.
19. Akiyama SK. Integrins in cell adhesion and signaling. Human Cell 1996;9:181-186.
20. Hughes DE, Salter DM, Dedhar S, Simpson R. Integrin expression in human bone. J Bone Mineral Res 1993;8:527-533.
21. Hautanen A, Gailit J, Mann DM, Ruoslahti E. Effects of modifications of the RGD sequence and its context on recognition by the fibronectin receptor. J Biol Chem 1989;264:1437-442.
22. Ochsenhirt SE, Tirrell M, Fields GB, Dillow AK. Use of supported thin films of peptide amphiphiles as model systems of the ECM to study the effect of structure-function phenomena on cell adhesion. In: Dillow AK, Lowman AM, editors. Biomimetic materials and design. New York: Marcel-Dekker; 2002. p 1-28.
23. Garcia AJ, Collard DM, Keselowsky BG, Cutler SM, Gallant ND, Byers BA, Stephansson SN. Engineering of integrin-specific biomimetic surfaces to control cell adhesion and function. In: Dillow AK, Lowman AM, editors. Biomimetic materials and design. New York: Marcel-Dekker; 2002. p. 29-55.
24. Irvine DJ, Ruzette AVG, Mayes AM, Griffith LA. Nanoscale clustering of RGD peptides at surfaces using comb polymers. 2. Surface segragation of comb polymers in polylactide. Biomacromolecules 2001;2:545-556.
25. Moursi AM, Damsky CH, Lull J, Zimmerman D, Doty SB, Aota SI, Gloubus RK. Fibronectin regulates calvarial osteoblast differentiation. J Cell Sci 1996;109:1369-1380.
26. Massia SP, Hubbell JA. An RGD spacing of 440 nm is sufficient for integrin alpha V beta 3-mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation. J Cell Biol 1991;114:1089-1100.
27. Rezania A, Johnson R, Leftkow AR, Healy KE. Bioactivation of metal oxide surfaces. Langmuir 1999;15:6931-6939.
28. Rezania A, Healy KE. The effect of peptide surface density on mineralization of a matrix deposited by osteogenic cells. J Biomed Mater Res 2000;52:595-600.
29. Barber TA, Golledge SL, Castner DG, Healy KE. Peptide-modified IPNs grafted to bulk titanium modulated osteoblast behavior in vitro. J Biomed Mater Res 2003;64:38-47.
30. Bearinger JP, Castner DG, Healy KE. Biomolecular modification of p(AAm-co-EG/AA) IPNs supports osteoblast adhesion and phenotypic expression. J Biomater Sci Polym Ed 1998;9:629-652.
31. Kornu R, Maloney WJ, Kelly MA, Smith RL. Osteoblast adhesion to orthopaedic implant alloys: effects of cell adhesion molecules and diamond-like carbon coating. J Orthoped Res 1996;14:871-877.
32. Drumheller PD, Elbert DL, Hubbell JA. Multifunctional poly(ethylene glycol) semiinterpenetrating polymer networks as highly selective adhesive substracts for bioadhesive peptide grafting. Biotech Bioeng 1994;4:772-780.
33. Jeon SI, Lee JH, Andrade JD, Degennes PG. protein surface interactions in the presence of polyethylene oxide. 1. Simplified theory. J Colloid and Interface Sci 1991;142:149-158.
34. Bjorling M. Interaction between surfaces with attached poly(ethylene oxide) chains. Macromolecules 1992;25:3956-3970.
35. Kenausis GL, Voros J, Elbert D, Huang NP, Hofer R, Ruiz-Taylor L, Textor M, Hubbell JA, Spencer ND. Poly(L-lysine)-g-poly(ethylene glycol) layers on metal oxide surfaces: Attachment mechanism and effects of polymer architecture on resistance to protein adsorption. J Phys Chem B 2000;104:3298-3309.
36. Huang NP, Michel R, Voros J, Textor M, Hofer R, Rossi A, Elbert DL, Hubbell JA, Spencer ND. Poly(L-lysine)-g-poly(ethylene glycol) layers on metal oxide surfaces: Surface-analytical characterization and resistance to serum and fibrinogen adsorption. Langmuir 2001;17:489-498.
37. VandeVondele S, Voros J, Hubbell JA. RGD-Grafted poly-L-lysine-graft-(polyethylene glycol) copolymers block non-specific protein adsorption while promoting cell adhesion. Biotech Bioeng 2003;82:784-790.
38. Textor M, Tosatti S, Wieland M, Brunette DM. Use of molecular assembly techniques for tayloring the chemical properties on smooth and rough surfaces. Boca Raton, FL: CRC Press; 2003.
39. Tosatti S, De Paul SM, Askendal A, Vande Vondele S, Hubbell JA, Tengvall P, Textor M. Peptide functionalized poly(L-lysine-g-poly (ethylene glycol) on titanium: resistance to protein adsorption in full heparinized human blood plasma. Biomaterials 2003;24:4949-4958.
40. Voros J, Ramsden JJ, Csucs G, Szendro I, Textor M, Spencer ND. Biotin-derivatized poly(L-lysine)-g-poly(ethylene glycol): A novel polymeric interface for bioaffinity sensing. Langmuir 2003;18:220-230.
41. Schwartz Z, Lohmann CH, Wieland M, Cochran DL, Dean DD, Textor M, Bonewald LF, Boyan BD. Osteoblast proliferation and differentiation on dentin slices are modulated by pretreatment of the surface with tetracycline or osteoclasts. J Periodontol 2000;71:622-633.
42. Boyan BD, Schwartz Z, Lohmann CH, Sylvia VL, Cochran DL, Dean DD, Puzas JE. Pretreatment of bone with osteoclasts affects osteoblast phenotypic expression. J Orthoped Res 2003;21:638-647.
43. Tosatti S, Michel R, Textor M, Spencer ND. Self-assembled monolayers of dodecyl and hydroxy-dodecyl phosphates on both smooth and rough titanium and titanium oxide surfaces. Langmuir 2002;18:3537-3548.
44. Wieland M, Hänggi P, Hotz W, Textor M, Keller BA, Spencer ND. Wavelength-dependent measurement and evaluation of surface topographies: Application of a new concept of window roughness and surface transfer function. Wear 2000;237:231-252.
45. Lohmann CH, Tandy EM, Sylvia VL, Hell-Vocke AK, Cochran DL, Dean DD, Boyan BD, Schwartz Z. Response of normal female human osteoblasts (NHOst) to 17β-estradiol is modulated by implant surface morphology. J Biomed Mater Res 2002;62:204-213.
46. Contu F, Elsener B, Bohni H. Characterization of implant materials in fetal bovine serum and sodium sulfate by electrochemical impedance spectrospcopy. J Biomed Mater Res 2002;62:412-421
47. Kurrat R, Textor M, Ramsden JJ, Boni P, Spencer ND. Instrumental improvements in optical waveguide light mode spectroscopy for the study of biomolecule adsorption. Rev Sci Instrum 1997;67:2172-2176.
48. 3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line. J Cell Physiol 1985;123:401-409.
49. 3 responsive alkaline phosphatase in osteoblast-like cells (ROS 17/2.8, MG 63, and MC 3T3) and growth cartilage cells in culture. J Biol Chem 1989;264:11879-11886.
50. Geivelis M, Turner DW, Pederson ED, Lamberts BL. Measurements of interleukin-6 in gingival crevicular fluid from adults with destructive periodontal disease. J Periodontol 1993;64:980-983.
51. Kieswetter K, Schwartz Z, Hummert TW, Cochran DL, Simpson J, Dean DD, Boyan BD. Surface roughness modulates the local production of growth factors and cytokines by osteoblast-like MG63 cells. J Biomed Mater Res 1996;32:55-63.
52. Boyan BD, Lohmann CH, Sisk M, Liu Y, Sylvia VL, Cochran DL, Dean DD, Schwartz Z. Both cyclooxygenase-1 and cyclooxygenase-2 mediate osteoblast response to titanium surface roughness. J Biomed Mater Res 2001;55:350-359.
53. 3 on differentiation of a human osteosarcoma (MG-63). J Biol Chem 1992;267:8943-8949.
54. Martin JY, Schwartz Z, Hummert TW, Schraub DM, Simpson J, Lankford J, Dean DD, Cochran DL, Boyan BD. Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63). J Biomed Mater Res 1995;29:389-401.
55. Martin JY, Dean DD, Cochran DL, Simpson J, Boyan BD, Schwartz Z. Proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63) cultured on previously used titanium surfaces. Clin Oral Implants Res 1996;7:27-37.
56. 3. J Biomed Mater Res 1998;39:77-85.
57. Hale LV, Kemick ML, Wuthier RE. Effect of vitamin D metabolites on the expression of alkaline phosphatase activity by epiphyseal hypertrophic chondrocytes in primary cell culture. J Bone Miner Res 1986;1:489-495.
58. Bretaudiere JP, Spillman T. Alkaline phosphatases. In: Bergmeyer HU, editor. Methods of enzymatic analysis. Weinheim, Germany: Verlag Chemica; 1984. p 75-92.
59. Sisk M, Lohmann CH, Cochran DL, Sylvia VL, Simpson JP, Dean DD, Boyan BD, Schwartz Z. Inhibition of cyclooxygenase by indomethacin modulates osteoblast response to titanium surface roughness in a time-dependent manner. Clin Oral Implants Res 2001;12:52-61.
60. 3 in three osteoblast-like cell lines (MC-3T3-E1, ROS 17/2.8, and MG-63). Bone 1992;13:51-58.
61. Saito T, Albelda SM, Brighton CT. Identification of integrin receptors on cultured human bone cells. J Orthoped Res 1994;12:384-394.
62. Stein GS, Lian JB, Owen TA. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 1990;4:3111-3123.
63. Lian JB, Stein GS. Concepts of osteoblast growth and differentiation: Basis for modulation of bone cell development and tissue formation. Crit Rev Oral Biol Med 1992;3:269-305.
64. Bellows CG, Aubin JE, Heersche JN, Antosz ME. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 1986;38:143-154.
65. Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas SL, Feng JQ, Ghosh-Choudhury N, Wozney JM, Mundy GR. Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 1994;9:855-863.
66. Bonewald LF, Mundy GR. Role of transforming growth factor-beta in bone remodeling. Clin Orthoped Rel Res 1990;250:261-276.
67. Dziak RM. Prostaglandins as mediators of bone cell metabolism. In: Rubin RP, Weiss GB, Putney JW, editors. Calcium in biological systems. New York: Plenum Publishing; 1985. p 533-539.
68. 2 on bone formation in cultured fetal rat calvariae: Interaction with cortisol. Endocrinology 1998;126:1654-1659.
69. 3. J Bone Miner Res 2000;15:1169-1180.
70. Maheshwari G, Brown G, Lauffenburger DA, Wells A, Griffith LG. Cell adhesion and motility depend on nanoscale RGD clustering. J Cell Sci 2000;113:1677-1686.
71. Healy KE, Harbers GM, Barber TA, Sumner DR. Osteoblast interactions with engineered surfaces. In: Davies JE, editor. Bone engineering. Toronto: em squared inc.; 2000. p 268-281.
72. Jeschke B, Meyer J, Jonczyk A, Kessler H, Adamietz P, Meenen NM, Kantlehner M, Goepfert C, Niles B. RGD-peptides for tissue engineering of articular cartilage. Biomaterials 2002;23:3455-3463.
73. Danilov YN, Juliano RL. (Arg-Gly-Asp)n-albumin conjugates as a model substratum for integrin-mediated cell-adhesion. Exp Cell Res 1989;182:186-196.
74. Jang JH, Ku Y, Chung CP, Heo SJ. Enhanced fibronectin-mediated cell adhesion of human osteoblast by fibroblast growth factor, FGF-2. Biotech Lett 2002;24:1659-1663.
75. Michel R, Lussi JW, Csucs G, Reviakine I, Danuser G, Ketterer B, Hubbell JA, Textor M, Spencer ND. Selective molecular assembly patterning: A new approach to micro- and nanochemical patterning of surfaces for biological applications. Langmuir 2002;18:3281-3287.
76. Koo LY, Irvine DJ, Mayes AM, Lauffenburger DA, Griffith LG. Co-regulation of cell adhesion by nanoscale RGD organization and mechanical stimulus. J Cell Sci 2002;115:1423-1433.
77. Olbrich KC, Andersen TT, Blumenstock FA, Bizios R. Surfaces modified with covalently-immobilized adhesive peptides affect fibroblast population motility. Biomaterials 1996;17:759-764.
78. Cook AD, Hrkach JS, Gao NN, Johnson IM, Pajvani UB, Cannizzaro SM, Langer R. Characterization and development of RGD-peptide-modified poly(lactic acid-co-lysine) as an interactive, resorbable biomaterial. J Biomed Mater Res 1997;35:513-523.
79. Harbers GM, Barber TA, Stile RA, Sumner DR, Healy KE. Mimetic peptide-modified materials for control of cell differentiation. In: Dillow AK, Lowman AM, editors. Biomimetic materials and design. New York: Marcel Dekker; 2002. p 55-90.
80. Mann BK, Tsai AT, Scott-Burden T, West JL. Modification of surfaces with cell adhesion peptides alters extracellular matrix deposition. Biomaterials 1999;20:2281-2286.
81. Chen CS, Mrksich M, Huang S, Whitesides GM, Ingber DE. Geometric control of cell life and death. Science 1997;276:1425-1428.